Skip to content
跳至主要內容
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
個股明細
Loading institutional stock data...
← BACK TO COCKPIT
ALL TICKERS →
OPTIONS CHAIN →
CHRS
Coherus Oncology, Inc.
NASDAQGM
Biotechnology
United States
$1.42
▲
+0.05 (+3.65%)
CLOSED
—
OPEN
$1.38
HIGH
$1.44
LOW
$1.38
PREV CLOSE
$1.37
VOLUME
304.1K
0.31x avg
BID / ASK
1.51 / 1.90
spr 0.390
MARKET CAP
$219.4M
DAY RANGE
$1.38
$1.44
P/E (TTM)
—
Fwd -2.3
EPS (TTM)
-1.24
DIV YIELD
—
52W HIGH
$2.62
-45.7%
52W LOW
$1.09
+30.3%
BETA
0.94
vs S&P 500
DES
FA
GP
OPT
HLDR
EARN
CMP
COMPARE
ASK DESK
AFTER-HOURS
$1.43
+0.01
(+0.70%)
LAST SURPRISE
—
—
NEXT EARNINGS
—
—
CATALYST
No fresh catalyst
—
ANALYST
—
—
SHORT INT
—
—
OPTIONS IV
—
—
CHRS
$1.42
▲
+3.65%
Chart
Valuation
Financials
Peers
News
CHRS · K 線技術分析（即時、可互動）
basic
pro
快速分析（約半分鐘，最長 5 分鐘）
K 線圖載入中…
按上方「快速分析」，研究台會以這張 K 線為起點跑一輪快速回答：三個分析師視角（總經、基本面、技術面）加交易計畫與風險統計，通常約半分鐘，上游壅塞時最長 5 分鐘。想要五隊深度研究與機構級報告，請在研究台把模式切到「深度」。
1-YEAR PRICE
一年走勢
RISK-ON
252 BARS · +10.1% YOY
1-year price chart. Started at 1.29, currently 1.42, up 10.1 percent. Range 1.10 to 2.51 over 252 data points.
2025-09-05
$1.29 → $1.42 (+10.1%)
2026-09-04
§ Valuation
Loading § Valuation
§ Multi-Year Financials
Loading § Multi-Year Financials
§ Peers
Loading § Peers
§ Recent News
Loading § Recent News
編輯內容 · 非投資建議。
資料來源：Finnhub（報價 / 公司資料 / 新聞 / 同業）＋ Yahoo（統計）＋ SEC EDGAR XBRL（財務 + DCF）。伺服器端數值經 ISR 快取，最長 60 分鐘；報價則在你的瀏覽器裡即時更新。
VALUATION
確定性估值（SEC EDGAR + Finnhub）
—
NO DCF
DCF Fair Value
—
DCF vs Spot
—
Comps Fair Value
$0.71
WACC Used
+7.0%
Terminal g
+3.5%
判定: strong-sell
· peers $0.71 (-50.1%)
同業:
ABOS
TNXP
KROS
ORGO
ARMP
PEPG
PLX PE12
CRBP
⚠ DCF skipped: missing FCF or shares data from SEC EDGAR. Often the case for non-US issuers.
FINANCIALS
多年財務（SEC XBRL）
—
4 FY · NO YOY
FY
Revenue
Net Income
OCF
FCF
Assets
2025-12
—
$168.0M
-$138.5M
—
$258.3M
2024-12
—
$28.5M
-$20.4M
—
$448.5M
2023-12
—
-$237.9M
-$174.9M
-$175.2M
$629.6M
2019-12
$123.9M
—
—
—
—
PEERS
同業與產業對照
CALM
10 PEERS · FINNHUB
ABOS
TNXP
KROS
ORGO
ARMP
PEPG
PLX
CRBP
NERV
950160.KQ
NEWS
近期新聞（過去 14 天）
CALM
10 HEADLINES · LAST 14 DAYS
Coherus to Participate in Upcoming Investor Conferences
GlobeNewswire · 2026-08-31
Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights
GlobeNewswire · 2026-08-17
Coherus Oncology (CHRS) Q2 2026 Earnings Call Transcript
Motley Fool · 2026-08-13
Coherus Oncology, Inc. Q2 2026 Earnings Call Summary
Moby · 2026-08-06
Coherus Oncology Inc (CHRS) (Q2 2026) Earnings Call Highlights: LOQTORZI Growth and Pipeline ...
GuruFocus.com · 2026-08-06
Coherus Oncology Q2 Earnings Call Highlights
MarketBeat · 2026-08-06
Coherus Oncology (CHRS) Reports Q2 Loss, Misses Revenue Estimates
Zacks · 2026-08-05
Coherus Oncology: Q2 Earnings Snapshot
Associated Press · 2026-08-05